{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T03:51:53Z","timestamp":1777521113402,"version":"3.51.4"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2008,11,28]],"date-time":"2008-11-28T00:00:00Z","timestamp":1227830400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eye"],"published-print":{"date-parts":[[2009,8]]},"DOI":"10.1038\/eye.2008.354","type":"journal-article","created":{"date-parts":[[2008,11,28]],"date-time":"2008-11-28T10:52:25Z","timestamp":1227869545000},"page":"1698-1701","source":"Crossref","is-referenced-by-count":36,"title":["Can a preoperative bevacizumab injection prevent recurrent postvitrectomy diabetic vitreous haemorrhage?"],"prefix":"10.1038","volume":"23","author":[{"given":"M R","family":"Romano","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S K","family":"Gibran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"Marticorena","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D","family":"Wong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H","family":"Heimann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,11,28]]},"reference":[{"key":"BFeye2008354_CR1","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1016\/S0161-6420(84)34099-4","volume":"91","author":"MA Novak","year":"1984","unstructured":"Novak MA, Rice TA, Michels RG, Auer C . Vitreous hemorrhage after vitrectomy for diabetic retinopathy. Ophthalmology 1984; 91: 1485\u20131489.","journal-title":"Ophthalmology"},{"key":"BFeye2008354_CR2","first-page":"1695.e1","volume":"113","author":"RL Avery","year":"2006","unstructured":"Avery RL, Pearlman J, Pieramici DJ, Rabena MD, Castellarin AA, Nasir MA et al. Intravitreal bevacizumab (Avastin) in the treatment of proliferative diabetic retinopathy. Ophthalmology 2006; 113: 1695.e1\u20131695.e15.","journal-title":"Ophthalmology"},{"key":"BFeye2008354_CR3","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1016\/S0002-9394(03)00718-9","volume":"136","author":"MB Landers","year":"2003","unstructured":"Landers MB, Perraki AD . Management of post-vitrectomy persistent vitreous hemorrhage in pseudophakic eyes. Am J Ophthalmol 2003; 136: 989\u2013993.","journal-title":"Am J Ophthalmol"},{"key":"BFeye2008354_CR4","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1016\/j.ophtha.2006.07.047","volume":"114","author":"CM Yang","year":"2007","unstructured":"Yang CM, Yeh PT, Yang CH . Intravitreal long-acting gas in the prevention of early postoperative vitreous hemorrhage in diabetic vitrectomy. Ophthalmology 2007; 114: 710\u2013715.","journal-title":"Ophthalmology"},{"key":"BFeye2008354_CR5","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1056\/NEJM199412013312203","volume":"331","author":"LP Aiello","year":"1994","unstructured":"Aiello LP, Avery RL, Arrigg PG, Keyt BA, Jampel HD, Shah ST et al. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engl J Med 1994; 331: 1480\u20131487.","journal-title":"N Engl J Med"},{"key":"BFeye2008354_CR6","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1097\/00006982-200603000-00004","volume":"26","author":"RF Spaide","year":"2006","unstructured":"Spaide RF, Fisher YL . Intravitreal bevacizumab (Avastin) treatment of proliferative diabetic retinopathy complicated by vitreous hemorrhage. Retina 2006; 26: 275\u2013278.","journal-title":"Retina"},{"key":"BFeye2008354_CR7","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1007\/s00417-008-0774-y","volume":"246","author":"S Rizzo","year":"2008","unstructured":"Rizzo S, Genovesi-Ebert F, Di Bartolo E, Vento A, Miniaci S, Williams G . Injection of intravitreal bevacizumab (Avastin) as a preoperative adjunct before vitrectomy surgery in the treatment of severe proliferative diabetic retinopathy (PDR). Graefes Arch Clin Exp Ophthalmol 2008; 246: 837\u2013842.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"BFeye2008354_CR8","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.ajo.2008.04.028","volume":"146","author":"CM Yang","year":"2008","unstructured":"Yang CM, Yeh PT, Yang CH, Chen MS . Bevacizumab pretreatment and long-acting gas infusion on vitreous clear-up after diabetic vitrectomy. Am J Ophthalmol 2008; 146: 211\u2013217.","journal-title":"Am J Ophthalmol"},{"key":"BFeye2008354_CR9","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1136\/bjo.84.8.822","volume":"84","author":"JF West","year":"2000","unstructured":"West JF, Gregor ZJ . Fibrovascular ingrowth and recurrent haemorrhage following diabetic vitrectomy. Br J Ophthalmol 2000; 84: 822\u2013825.","journal-title":"Br J Ophthalmol"},{"key":"BFeye2008354_CR10","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1097\/01.icu.0000143685.60479.3b","volume":"15","author":"GM Comer","year":"2008","unstructured":"Comer GM, Ciulla TA . Pharmacotherapy for diabetic retinopathy. Curr Opin Ophthalmol 2008; 15: 508\u2013518.","journal-title":"Curr Opin Ophthalmol"},{"key":"BFeye2008354_CR11","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1046\/j.1440-1681.1999.03025.x","volume":"26","author":"T Warner","year":"1999","unstructured":"Warner T . Relationships between the endothelin and nitric oxide pathways. Clin Exp Pharmacol Physiol 1999; 26: 247\u2013252.","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"BFeye2008354_CR12","first-page":"747","volume":"9","author":"D Kent","year":"2003","unstructured":"Kent D, Sheridan C . Choroidal neovascularization: a wound healing perspective. Mol Vis 2003; 9: 747\u2013755.","journal-title":"Mol Vis"}],"container-title":["Eye"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/eye2008354.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/eye2008354","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/eye2008354.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T17:06:09Z","timestamp":1684429569000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/eye2008354"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,11,28]]},"references-count":12,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2009,8]]}},"alternative-id":["BFeye2008354"],"URL":"https:\/\/doi.org\/10.1038\/eye.2008.354","relation":{},"ISSN":["0950-222X","1476-5454"],"issn-type":[{"value":"0950-222X","type":"print"},{"value":"1476-5454","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,11,28]]}}}